Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Annidis Corporation V.RHA.H

Annidis Corp is a Canada based company engaged in the principal activities related to the research, development, and sale of the medical device to eye-care professionals. It offers RHA instrument and RHA report. The RHA instrument is a multi-spectral imaging digital ophthalmoscope with a patented optical system that captures high-resolution image data through the retinal and subretinal layers... see more

TSXV:RHA.H - Post Discussion

Annidis Corporation > It would be interesting to know
View:
Post by las5513 on May 11, 2018 8:51am

It would be interesting to know

if RHA intends to file the required financials to permit this stock to resume trading or just go straight to liquidation and bankruptcy. I suspect in liquidation the assets are probably worthless which means everyone gets screwed.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities